Investor Relations

everything you need to make informed investment decisions

recent releases
View all
Jul 17, 2024
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets

Press release

- Nufarm to pay up to USD $5 million in consideration for the license -The parties will negotiate the sale of essentially all of Yield10’s assets to Nufarm WOBURN, Mass. and WEST SACRAMENTO, Calif. , July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC: YTEN ) (“Yield10” or the

events & presentations
View all
May 17, 2024
Investor Slide Deck May 2024
Apr 1, 2024 4:30 PM EDT
Yield10 Bioscience Fourth Quarter 2023 Earnings Call
Mar 14, 2024
ABLC 2024 Presentation by Kristi Snell
recent sec filings
View all
 
D
external link icon
D
external link icon

25-NSE

external link icon

A preliminary proxy statement providing notification matters to be brought to a vote

external link icon